Torrent Pharma Inc. has recalled 15,384 bottles of Lamotrigine Extended-Release Tablets (200 mg), a medication used to treat seizures and bipolar disorder. The recall was initiated because the tablets failed a dissolution test during stability testing, meaning they may not release the medication into the body at the correct rate. Consumers should contact their healthcare provider or pharmacist regarding this recall and to obtain a replacement prescription.
The tablets did not meet specifications for how the drug dissolves over a 5-hour period. If the medication dissolves too slowly or too quickly, it could lead to inconsistent blood levels of the drug, potentially reducing its effectiveness in controlling seizures or mood symptoms.
Contact healthcare provider and return product for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.